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Substrate bindingIntracellular proteolysis is a tightly regulated process responsible for the targeted removal of unwanted or
damaged proteins. The non-lysosomal removal of these proteins is performed by processive enzymes, which
belong to the AAA+superfamily, such as the 26S proteasome and Clp proteases. One important protein
degradation pathway, that is common to both prokaryotes and eukaryotes, is the N-end rule. In this pathway,
proteins bearing a destabilizing amino acid residue at their N-terminus are degraded either by the ClpAP
protease in bacteria, such as Escherichia coli or by the ubiquitin proteasome system in the eukaryotic
cytoplasm. A suite of enzymes and other molecular components are also required for the successful
generation, recognition and delivery of N-end rule substrates to their cognate proteases. In this review we
examine the similarities and differences in the N-end rule pathway of bacterial and eukaryotic systems,
focusing on the molecular determinants of this pathway. This article is part of a Special Issue entitled: AAA
ATPases: structure and function.Crown Copyright © 2011 Published by Elsevier B.V. All rights reserved.1. Introduction
Protein degradation is an important cellular function that is carried
out in a highly regulated manner. It involves a vast array of protein–
protein interactions that incorporate a number of environmental and
cellular cues with gene regulation and post-translational protein
modiﬁcations. The non-lysosomal degradation of cellular proteins is
performed, in all kingdoms of life, by processive enzymes such as the
26S proteasome or Clp proteases. These proteolytic machines use
members of the AAA+(ATPase associated with various cellular
activities) superfamily [1] to recognize and remodel diverse target
proteins (substrates) for degradation. As such, regulatory aspects of
many important cellular processes such as cell division, development,
apoptosis, stress adaptation, proteostasis, transcriptional regulation
and DNA repair can be spatially and temporally controlled by these
proteolytic machines [2–5].
Although the recognition, unfolding and degradation of a substrate
are complex processes, some general principles can be described. A
protein that is committed to a proteolytic pathway will possess a
primary degradation signal often referred to as a degron. A degronmay
arise from post-translational modiﬁcation of the target protein, such as
the enzymatic addition or removal of amino acids, acetylation,
phosphorylation or oxidation of speciﬁc amino acid side chains orTPases: structure and function.
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11 Published by Elsevier B.V. All rigfrom a conformational change in the protein. Alternatively, a degron
may become exposed on a protein, due to changes in its interaction
partners (i.e. association/dissociation of a partner protein, peptide,
metabolite or cofactor). In eukaryotes, substrates are initially recog-
nized by an E3 ligase resulting in the covalent attachment of ubiquitin.
The polyubiquitin chain mediates recognition of the target protein by
the 26S proteasome, and eventually its fait. In contrast to the ubiquitin-
dependent protein degradation system used by eukaryotes, bacteria
have retained a simple ubiquitin independent version of this process, in
which primary degron recognition is directly coupled with substrate
delivery to the cognate protease. This process (of substrate recognition
and delivery) is performed by factors known as adaptors, which in
many ways resemble E3 ligases. The use of specialized adaptors is a
common strategy employed by AAA+proteins to expand their
repertoire of targets or functions [6,7]. Interestingly, in the N-end rule
pathway, a direct evolutionary link exists between a bacterial adaptor
protein and a eukaryotic E3 ligase [8].2. The N-end rule
2.1. The "classic" pathway
The N-end rule relates the metabolic stability of a protein to the
N-terminal residue of that protein [9]. The pathway was originally
discovered in the laboratory of Alex Varshavsky, based on the
unexpected observation that the half-life of an otherwise stable β-
galactosidase fusion protein, produced in Saccharomyces cerevisiae,hts reserved.
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identity of the N-terminal residue of that protein [10]. As such, N-
terminal residues were described as “stabilizing” if the β-galactosi-
dase fusion protein exhibited a long half-life (i.e. ~ 20 h) or
“destabilizing” if the β-galactosidase fusion protein was short-lived
(i.e. with a half-life of ~3 min). These N-terminal destabilizing
residues are known as N-degrons. Since its initial discovery in yeast
[10], the N-end rule has also been identiﬁed in a broad range of
organisms, including bacteria [11], plants [12] and mammals [13]. In
addition, through a variety of genetic, biochemical and structural
approaches, numerous components (and a handful of substrates) of
the various different pathways have been identiﬁed [8,14–20].
Each pathway shares a hierarchical structure, however the details of
this hierarchy vary from one organism to the next. In bacteria,
destabilizing residues are divided into two groups; primary and
secondary destabilizing residues (Fig. 1A). Classically, secondary
destabilizing residues were deﬁned as basic amino acids (Arg and
Lys), which act as a signal for the post-translational attachment of a
primary destabilizing residue (Leu or Phe), by leucyl/phenylalanyl-
tRNA-protein transferase (LFTR), to the N-terminus of the target
protein. However, with the recent identiﬁcation of the ﬁrst natural
substrate of LFTR in E. coli (Putrasceine aminotransferase (PATase), see
later), methionine can also be considered a secondary destabilizing
residue [17] (Fig. 1A). Moreover, the identiﬁcation of an alternative
L-transferase (Bpt) in the human pathogen, Vibrio vulniﬁcus, has
established that acidic residues (Asp and Glu) may also serve as
secondary destabilizing residues, at least in some bacterial species [21]
(Fig. 1A). Despite this variation in the identity of secondary destabilizingFig. 1. The N-end rule pathway exists in bacteria, yeast, plants and mammals. A. The “classi
amino acid and as such N-terminal amino acids can be described as either “stabilizing” or “de
levels, primary (green) and secondary (yellow). Eukaryotes also contain an additional hierarc
Q) is performed by a single enzyme in yeast (NTA1). Arginylation (†) in plants, is performe
recognized by an N-recognin. In bacteria only a single N-recognin has been identiﬁed (ClpS)
contains, either a UBR box, a ClpS domain or both. The target protein is degraded, either by C
N-end rule pathway has been identiﬁed – the Ac-N-end rule pathway – for the recognition an
like the “classic” N-end rule pathway is hierarchical and proteins are recognized by the speci
substrates may be generated by one of three proposed mechanisms. (I) Cleavage of the initia
and plants. Alternatively, this same process can expose a secondary destabilizing residue for t
expose a primary, secondary or tertiary destabilizing residue in the protein. (III) In E. coli a pri
currently it is unclear if the residues adjacent to the initiating Met play a role in LFTR speciresidues in bacteria, primary destabilizing residues are limited to bulky
hydrophobic amino acids (Leu, Phe, Tyr and Trp), which are recognized
directly by the bacterial N-recognin known as ClpS [8,22,23] and
delivered to the ClpAP protease for degradation (Fig. 1A).
In contrast to bacteria, destabilizing residues in eukaryotes can be
classiﬁed into three hierarchical levels; primary, secondary and tertiary
(Fig. 1A). In this case, primary destabilizing residues fall into two
categories, type 1 (Arg, Lys andHis) and type 2 (Ile, Leu, Phe, Tyr and Trp)
which are recognized by discrete binding sites within the eukaryotic N-
recognins (see later). In general, tertiary destabilizing residues (Asn, Gln
and Cys) are ﬁrst modiﬁed, either enzymatically (by deamidation of Asn
or Gln) or chemically (by oxidation of Cys), to generate a secondary
destabilizing residue (Asp, Glu and oxidized Cys (C*), respectively).
Finally, the modiﬁed N-terminal amino acids is arginylated to create a
substrate bearing a type 1 primary destabilizing residue (Arg).
In spite of the conserved nature of the N-end rule pathway
(especially amongst eukaryotes), deamidation of Asn and Gln is
performed by three unrelated enzymes in eukaryotes (Fig. 1A). In
yeast, deamidation of both Asn and Gln is performed by a single N-
terminal amidohydrolase (Nt-amidase) known as NTA1 [24], while in
mammals and plants, deamidation of Asn and Gln is performed by two
separate Nt-amidases (NTAN1/AtNTAN1 and NTAQ1/AtNTAQ1, respec-
tively), both of which are unrelated to the yeast NTA1 protein sequence.
Another point of difference between the N-end rule pathway in higher
and lower eukaryotes, is that plants and mammals, unlike yeast,
contain an additional tertiary destabilizing residue (Cys) [13] (Fig. 1A).
In this case, the oxidation of Cys generates amodiﬁed N-terminus (Cys-
sulfonic acid or Cys-sulﬁnic acid), which is structurally similar to thec” N-end rule pathway relates the half-life of a protein to the identity of its N-terminal
stabilizing”. Destabilizing amino acids are hierarchical, and in bacteria they fall into two
hical layer—tertiary (red). Deamidation (#) of the tertiary destabilizing residues (N and
d by two ATE1 sequelogs (AtATE1 and AtATE2). All primary destabilizing residues are
, while in eukaryotes several different N-recognins have been identiﬁed, each of which
lpAP (in bacteria) or the proteasome (in eukaryotes). B. In yeast a specialized arm of the
d degradation of proteins that are acetylated at their N-terminal residue. This pathway,
alized N-recognin, Doa10, and degraded by the proteasome. C. Physiological N-end rule
ting Met, by MetAP, exposing a “classic” tertiary destabilizing residue (Cys) in mammals
he Ac-N-end rule pathway in yeast. (II) Endopeptidase cleavage of a “pre-N-degron” can
mary destabilizing residue is attached directly to the N-terminal initiatingMet, however
ﬁcity.
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(Arg) is then attached to proteins bearing an N-terminal secondary
destabilizing residue (Asp, Glu or Cys*), by an R-transferase [25].
Intriguingly, in yeast and mammals the arginylation of secondary
destabilizing residues is performed by a single R-transferase (ATE1),
while in plants two functionally redundant sequelogs (ATE1 and ATE2)
appear to perform this role [26,27]. Finally, regardless of their origin, all
target proteins bearing a primary destabilizing residue are recognized
by the appropriate recognition factor known as an N-recognin, and
ultimately degraded by the 26S proteasome (Fig. 1A).
2.2. The Ac-N-end rule: a specialized branch of the N-end rule pathway
Recently in yeast, a new branch of the N-end rule pathway was
discovered [28]. This pathway, termed the Ac-N-end rule, is
responsible for the recognition and degradation of proteins that
contain an acetylated N-terminal residue (Fig. 1B). Although it was
known for more than 20 years that some N-terminally acetylated
proteins could be degraded by the ubiquitin system, it was assumed
that the relevant degradation signals were internal, i.e., located
downstream of the N-terminal residue [29]. In 2010, Varshavsky and
colleagues [28] not only discovered the critical proteolytic role of
N-terminally acetylated residues but also identiﬁed several natural
substrates of this new branch of the N-end rule pathway as well as the
E3 ubiquitin ligase responsible for the recognition of N-terminally
acetylated N-end rule substrates. Similar to the “classic” N-end rule
pathway, N-terminal residues in the Ac-N-end rule pathway can be
classiﬁed as stabilizing or destabilizing. Destabilizing residues are
hierarchical in nature and fall into two categories. Secondary
destabilizing residues (Met, Ala, Val, Ser, Thr and Cys) are acetylated
by one of four N-terminal acetylases (NatA, NatB, NatC, NatD), either
before or after removal of the N-terminal Met, by MetAP [30], to
generate a primary destabilizing residue (Ac-X,where X=Met, Ala, Val,
Ser, Thr and Cys) (Fig. 1B). Not surprisingly, substrates bearing an Ac-N-
degron are recognized by an E3 ligase unrelated to the N-recognins of
the “classic” N-end rule pathway (see later). In this case, the E3 ligase
(Doa10 in yeast, also known as TEB4 in mammals) is anchored in the
endoplasmic reticulum (ER) membrane and inner nuclear membrane,
where it is responsible for mediating the degradation of cytosolic and
nuclear proteins [31]. Although acetylation of the N-terminal residue is
essential for recognition, this alone is not sufﬁcient for degradation to
proceed, and hence it has been suggested that the Ac-N-end rule is a
conditional pathway that may monitor protein folding and assembly
[28]. Consistent with this idea the vast majority of yeast proteins are
stable, even though ~50% of them are N-terminally acetylated.
3. Physiological roles of the N-end rule pathway
To date, the N-end rule pathway has largely been deﬁned using a
series of artiﬁcial substrates. This approach has lead to a detailed
understanding of many of the general principles of the pathway
including the identiﬁcation of the numerous components. However to
date, relatively few substrates have been identiﬁed, and hence our
current understanding of how bona ﬁde N-end rule substrate are
generated remains incomplete. Nevertheless, during the past decade
considerable progress has been made in understanding the physiolog-
ical role of this pathway. Indeed, the N-end rule pathway contributes to
a diverse range of cellular processes in a variety of different organisms;
from genome maintenance to the regulation of peptide import in yeast
[32,33], the regulation of leaf senescence and seed germination in
plants [26], apoptosis in ﬂies [34] and spermatogenesis, cardiovascular
development and the sensing of heme and oxygen in mammals [35–
37]. Genetic analysis has also linked the N-end rule pathway to the
pathogenesis of human disease [38,39].
Currently, two general mechanisms (Fig. 1C, I and II) and one
seemingly speciﬁc approach (Fig. 1C, III) to generate a substrate bearingan N-terminal destabilizing residue have been proposed. The ﬁrst
mechanism (Fig. 1C, I) relies solely on the N-terminal processing, by
methionine aminopeptidase (MetAP), of the initiating Met from the
target protein. Although this method is not expected to generate a
“classic”N-end rule substrate in bacteria or yeast, (due to the speciﬁcity
of MetAP which precludes the removal of Met when adjacent to a
“classic” primary or secondary destabilizing residue) it is responsible
for the generation of “classic” N-end rule substrates in higher
eukaryotes (exposing Cys, a tertiary destabilizing residue) and Ac-N-
end rule substrates in yeast (exposing several secondary destabilizing
residues—Met, Ala, Val, Ser, Thr and Cys). Indeed in mammals, several
regulators of G protein signaling (RGS4, RGS5 and RGS16) are
arginylated by ATE1 (at Cys2) following removal of the initiating Met,
by MetAP [16,40,41]. Importantly, the arginylation and hence turnover
of these proteins is dependent on the oxidation of Cys2, which requires
nitric oxide (NO) and oxygen [37,41]. Given that ATE1 and RGS proteins
have been implicated in cardiovascular development it has been
proposed that the N-end rule pathway acts as a sensor of NO and
oxygen to regulate cardiovascular signaling [16,41]. Currently however,
the relative importance of N-terminal arginylation (resulting in
degradation) and internal arginylation, by ATE1, of proteins in
cardiovascular development remains to be determined.
In the second case, a pre-N-degron is processed by an endopep-
tidase (e.g. separase, caspase or calpain) resulting in the exposure of a
destabilizing residue (primary, secondary or tertiary) at the N-
terminus of the newly generated C-terminal fragment (Fig. 1C, II).
Although this approach is expected to produce a vast number of
physiological N-end rule substrates, it is dependent on the transient
activation of a speciﬁc protease and hence currently only a handful of
substrates have been identiﬁed. In yeast, the processing of SCC1 (a
component of cohesin) by the ESP1 separin generates a C-terminal
fragment, which contains an N-terminal primary destabilizing residue
(Arg). The UBR1-mediated degradation of this fragment by the N-end
rule pathway is essential for chromosome stability [33]. Consistently,
the overexpression of a stable C-terminal fragment of SCC1 is lethal in
yeast cells [33]. This process appears to be conserved in mammals, as
an equivalent cleavage event has been identiﬁed in the mammalian
homolog of SCC1, although in this case a secondary destabilizing
residue (Glu) is exposed [42]. However, currently it remains unclear if
this fragment is degraded by the N-end rule pathway.
In an unexpected ﬁnding, the degradation of an inhibitor of
apoptosis protein (IAP) from Drosophila melanogaster (DIAP1), by the
N-end rule pathway, was shown to be essential for the regulation of
apoptosis in the ﬂy [34]. Normally, IAPs control caspase activation
through the removal of pro-apoptotic factors. However, in this case,
DIAP1 is cleaved by the effector caspase (DrICE) to expose an N-
terminal tertiary destabilizing residue (Asn), which following deami-
dation and arginylation, leads to its degradation by the proteasome
[34]. It is proposed that the targeted degradation of this fragment is
responsible for the mutual destruction of its pro-apoptotic ligands,
such as caspases and Reaper and hence the degradation of DIAP1, by
the N-end rule pathway, is essential for suppression of apoptosis in
the ﬂy.
In a more recent example, the bacterial protein, DNA protection
during starvation (Dps), was identiﬁed as a ClpS-interacting protein in
two independent studies [17,18]. In this case, a truncated form of Dps
(Dps6-167) is created by an unidentiﬁed endopeptidase, following
removal of the initiating Met (by MetAP). This second processing
event, exposes an N-terminal primary destabilizing residue (Leu) on
the C-terminal fragment of Dps. Interestingly, although processing of
the N-terminal region of Dps (i.e. removal of residues 2–5) is essential
for the ClpS-mediated recognition and delivery to ClpAP for
degradation [17,18], it simultaneously prevents its degradation by
the AAA+protease, ClpXP [43]. Hence, it is possible that truncation of
the Dps N-terminus, creates a proteolytic switch that modiﬁes the
cellular function of Dps. Consistent with this idea, an N-terminal
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retains the ability to sequester Fe(II) [44]. Nevertheless, the current
physiological relevance of Dps processing and the peptidase respon-
sible for this cleavage remains unknown.
In a ﬁnal, and possibly unique case, the N-end rule pathway was
shown to control the half-life of PATase, an E. coli enzyme involved in
the catabolism of putrescine [17,18]. In this case, the turnover of
PATase is dependent on the addition of Leu or Phe to the N-terminus,
by LFTR, and hence represents the ﬁrst physiological substrate of LFTR.
However, in an unexpected twist, the attachment of Leu or Phe by
LFTR was not to a classic secondary destabilizing residue (Arg or Lys)
but rather to the initiating Met of PATase [17,45], suggesting that the
speciﬁcity of LFTR may be broader than previously thought (Fig. 1C,
III). Currently, however, the physiological relevance of PATase
turnover by the N-end rule remains unclear, although it has been
suggested that it may help to regulate cellular putrescine levels
[17,18]. Alternatively, the modiﬁcation of the N-terminal Met of
PATase, by LFTR, may serve as a method to monitor the assembly of
PATase into its ﬁnal oligomeric state (V. Schuenemann, K. Zeth and
D.A.D, unpublished) as was recently proposed for substrates of the Ac-
N-end rule pathway [28].
4. N-degron recognition domains: ClpS and the UBR box
N-recognins, in bacteria and eukaryotes alike, are deﬁned by their
ability to bind proteins bearing a primary destabilizing residue. Bacterial
N-recognins, however, only recognize bulky hydrophobic residues, while
eukaryotic N-recognins recognize basic (Arg, Lys and His) and bulky
hydrophobic (Ile, Leu, Phe, Tyr and Trp) residues. Indeed, each group of
destabilizing residues is recognized by unique binding pocketswithin the
N-recognin; bulky hydrophobic destabilizing residues (type 2) are
recognized by the “bacterial” ClpS-domain (Fig. 2), while basic destabiliz-
ing residues (type 1) are recognized by a novel zinc binding domain
known as the UBR box (Fig. 2A, upper panel and Fig. 3).
Recently, the molecular details of these interactions were
determined for both the bacterial ClpS domain [22,23,46] and the
eukaryotic UBR box [47,48]. This has enabled a comparison of the
strategies employed by the different binding pockets to speciﬁcally
recognize different classes of N-terminal residues. N-degron recogni-
tion by ClpS involves a network of interactions with both the side
chain of the ﬁrst amino acid and the peptide backbone of the ﬁrst two
amino acids (Fig. 2B, C and D). The surface cavity of the N-degron
binding pocket on ClpS is lined predominately with polar (Asn34,
Asp35, Asp36, Thr38, His66) residues, which form a network of
hydrogen bonds with the backbone of the ﬁrst two residues of the
substrate (Fig. 2C and D). Both the α-amino group and the peptide
bond of the N-degron are involved in critical interactions with ClpS
[22,23,46]. Consistently, mutation of Asp35, Asp36, Thr38 or His66 to
alanine, in E. coli ClpS, abolishes the interaction of all N-degrons (8, 22,
S. Spall, K.N.T. and D.A.D, unpublished). Importantly, two other
residues (Met40 andMet62)which line the binding pocket, also play a
crucial role in N-degron binding, however in contrast to the polar
residues (above), which are essential for N-degron binding, these
residues form hydrophobic interactions with the side chain of the N-
terminal residue and hence contribute to the speciﬁcity of the
interaction [22]. Consistently, mutation of Met40 to alanine extends
the speciﬁcity of bacterial ClpS to include the eukaryotic type 2
destabilizing residue (Ile), although this broader speciﬁcity comes at
the expense of high afﬁnity binding to the remaining type 2
destabilizing residues (Leu, Phe, Tyr and Trp) [23, S. Kralik, K.N.T.
and D.A.D., unpublished]. It will be interesting to see how eukaryotes
have adapted the ClpS binding pocket to recognize Ile with high
afﬁnity, whilst maintaining high afﬁnity binding to all other primary
destabilizing residues.
Similar to N-degron recognition by ClpS, the UBR box of eukaryotic
N-recognins (Fig. 3) interacts with, both the side chain of the ﬁrstamino acid and the peptide backbone of the ﬁrst two amino acids of
the substrate (Fig. 3). However, in contrast to ClpS (in which the N-
terminal side chain of the substrate is buried in a hydrophobic pocket)
the N-terminal side chain of type 1 destabilizing residues (Arg, Lys
and His), is bound in a shallow, negatively charged groove, of the UBR
box (Fig. 3B). Consistently, mutagenesis of the interface indicates that
the H-bond network that coordinates the α-amino group of the N-
degron (Fig. 3D, Asp150) is critical for binding of all type 1 N-degrons.
In contrast, mutagenesis of the acidic residues that line the “side
chain” binding groove in S. cerevisiae UBR1 (Fig. 3C, Asp142 and
Asp179) only modulate substrate binding [47–49] and therefore
appear to contribute to substrate speciﬁcity in a similar manner to
Met40 and Met62, which line the hydrophobic pocket of ClpS [22].
The UBR box is composed of two conserved Cys/His rich motifs,
which coordinate three zinc ions, one motif coordinates a single zinc
ion, while the othermotif coordinates two zinc ions. Although the vast
majority of the residues required for coordinating these zinc ions are
absolutely conserved across all UBR box proteins, one residue is
surprisingly poorly conserved. Indeed, it appears that the ﬁnal residue
required for coordinating the last zinc ion is promiscuous and may be
supplied by either of two residues located at opposite ends of the UBR
box. For example, in human UBR1 this role is performed by His166
[48], while in yeast UBR1 the same function is performed by His118
[47], which is equivalent to Gly94 in human UBR1 (Fig. 3A).
Interestingly, although the presence of either a ClpS-domain or a
UBR box is generally necessary for the recognition of an N-degron, this
alone is not sufﬁcient and hence not all UBR box proteins are capable
of N-degron recognition. For example, yeast contains two UBR box
proteins (Ubr1p and Ubr2p), however only Ubr1p plays a role in the
N-end rule pathway [50]. Similarly, seven different UBR box proteins,
namedUBR1 to UBR7, have been identiﬁed inmammals [19], however
only four (UBR1, UBR2, UBR4 and UBR5) have been shown to bind
primary destabilizing residues [49](Fig. 3A). Plants, on the other hand,
contain three UBR box proteins, one of which (proteolysis-6 (PRT6), a
sequelog of UBR1) has been implicated in the N-end rule pathway
[51]. A role for the remaining proteins in the plant N-end rule pathway
has yet to be determined, although BIG (a putative UBR4 homolog
[19]), but not At4g23860 (a putative UBR7 homolog), is likely to be
involved in the pathway. Nevertheless, in light of the recent UBR box
structures, it is noteworthy that both BIG and A. thaliana UBR7 lack
several of the key residues required for N-degron recognition,
including the promiscuous His residue that coordinates the last zinc
ion. Although, it should be noted that human UBR4 also lacks several
of these key residues and yet it retains the ability to bind type 1
destabilizing residues [49].
As expected from the predicted domain structure, mammalian N-
recognins, UBR1 and UBR2 and yeast Ubr1p recognize both types of
destabilizing residues, while mammalian UBR5 (and PRT6 from
plants), which lack a ClpS-domain, only recognize basic destabilizing
residues. Surprisingly however, mammalian UBR4, which lacks a ClpS-
domain, retains the ability, albeit poorly, to bind both type 1 and type
2 destabilizing residues [49]. This suggests that a unique domain
within UBR4, is responsible for the recognition of proteins bearing
N-terminal bulky hydrophobic residues. Plants also contain an N-
recognin (known as PRT1), which appears to lack both the UBR box
and ClpS-domain [52] and hence it's currently unclear how this
protein interacts with an N-degron.
5. AAA+ proteases
5.1. Degradation of N-end rule substrates
Regardless of how N-end rule substrates are generated and
recognized, all are delivered to, and degraded by, an ATP-dependent
proteolytic machine (either ClpAP in bacteria, the 26S proteasome in
eukaryotes and possibly ClpCP in plastids [53])(Fig. 4). These
Fig. 2. The ClpS domain is responsible for the recognition of type 2 destabilizing residues. A. Upper panel; Cartoon indicating the relative position of the type 1 binding site (UBR box,
white box) and the type 2 binding site (ClpS domain, black box) in E. coli ClpS and Human UBR1. The RING domain (gray box) in also indicated for human UBR1. Lower panel, protein
sequence alignment of the type 2 N-degron binding region of several bacterial and plant ClpS homologs (E. coli (P0A8Q6), C. crescentus (Q9A5I0), V. vulniﬁcus (Q8DAS0) and
A. thaliana (Q9SX29) together with several eukaryotic N-recognins, which contain a ClpS domain (Human UBR1 (Q8IWV7) and UBR2 (Q8IWV8) and S. cerevisiae UBR1 (P19812)).
Numbering is deﬁned by E. coli ClpS. Important N-degron contact residues (as deﬁned by the interaction with E. coli ClpS are colored as follows, residues that contact the α-amino
group of the N-terminal amino acid (Asn34, and Asp35) are in red, residues that interact with the peptide bond (Thr38 and His66) are in blue and pocket speciﬁcity resides (Met40
andMet62) are in green. B. Molecular surface showing the electrostatic potential of the C-terminal domain of ClpS from the top. The surface is shaded in red (negatively charged) and
blue (positively charged). The bound N-degron peptide (LV) is shown in green. C-D. H-bond network (dotted lines) of selected residues that comprise the N-degron–binding pocket
for (C) E. coli ClpS (pink) in complex with LV (green) (PDB: 2W9R) or (D) either C. crescentus ClpS (dark blue) in complex with LL-peptide (green) (PDB: 3G19) or in the absence of
peptide (cyan, PDB: 3GQ0). Figures were prepared using the program MacPyMOL (http://www.pymol.org).
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similar as each machine is composed of two components; a peptidase
and a regulator. The regulator, also known as a gate keeper, can be
found at one or both ends of the peptidase [54]. The compartmental
arrangement of these machines is crucial for their proper function, as
it couples ATP-dependent unfolding of the substrate with entry into
the peptidase core, while simultaneously preventing the unregulated
entry of native proteins into the protease active chamber. The
importance of correctly regulating substrate access into these
machines is exempliﬁed by the fact that acyldepsipeptide antibiotics
(ADEP) kill bacteria by activating ClpP for unregulated degradation of
nascent polypeptides [55,56].
The peptidase component (either ClpP or the 20S core particle (CP)
of the proteasome) is a barrel-shaped oligomer with both protein
complexes exhibiting a 7-fold symmetry. ClpP is composed of 14
copies of a single subunit which form two-heptameric rings stacked
back-to-back [57]. The active sites are located within the central
cavity of this barrel-shaped structure and substrate access is limited to
a narrow 10 Å portal located at the distal ends of the complex. In
contrast, the eukaryotic CP is composed of 28 subunits, which form
four-heptameric rings; two rings of 7 different α-subunits (α1–α7)
and two rings of 7 different β-subunits (β1–β7). However, only the
β-subunits (located in the inner rings) are catalytically active, while
outer rings (composed of α-subunits) are catalytically inactive [58].
Consequently, these four rings assemble to create three chambers,
two antechambers and a central proteolytic chamber (Fig. 4A). Access
to this central chamber, as is also the case for ClpP, is restricted to a
narrow portal located at either end of the particle, which in the
absence of its gate keeper, is occluded by the N-terminal ends of the
α-subunits [59,60].The gate keepers of these machines (either ClpA or the 19S
regulatory particle (RP), respectively) are not only responsible for
regulating access into the proteolytic chamber, but they also prepare
the substrate for degradation. For both machines substrate prepara-
tion involves the unfolding and translocation of the substrate into the
peptidase. In the case of ClpAP, this task is performed by a single
protein, ClpA [61]. In contrast, substrate processing by the eukaryotic
proteasome involves an additional task—the removal of ubiquitin
(Ub) prior to unfolding—which requires the co-ordinated action of
~19 different proteins that make up the RP [62]. Indeed these two
functions are housed in separate parts of the RP, the lid is responsible
for removal of Ub, while the base is responsible for substrate
unfolding and activation of the CP (Fig. 4). Regardless of the
complexity of these machines, the unfoldase components are
composed of proteins belonging to the AAA+superfamily which, in
the presence of ATP, form hexameric ring-shaped structures [1]. ClpA
is a homohexamer, while the unfoldase component of the RP is
composed of 6 different AAA+proteins (Rpt1–Rpt6). These hexame-
ric complexes make a number of speciﬁc interactions with the
peptidase, which are crucial for activation of the peptidase. In the case
of the proteasome, activation or “gate opening” of the CP entry portal
is triggered by docking of a tripeptide motif (HbYX, where Hb is
hydrophobic and X is any amino acid), located on the C-termini of
Rpt2 and Rpt5, into an intersubunit pocket on the CP [63–65](Fig. 4A).
Similarly, the docking of ClpA, to ClpP, is mediated by a speciﬁc
interaction between a surface exposed loop on the unfoldase
containing a conserved tripeptide motif (IGF/L) and a hydrophobic
pocket on the apical surface of ClpP [66](Fig. 4B). This binding results
in activation or “gate opening” of ClpP, by displacing most, if not all, of
the seven N-terminal loops that block access into the proteolytic
Fig. 3. The UBR box of eukaryotic N-recognins is responsible for the recognition of type 1 destabilizing residues. A. Protein sequence alignment of the UBR box of selected UBR
proteins from yeast, plants and humans. Human UBR1 (Q8IWV7), UBR2 (Q8IWV8), UBR4 (Q5T4S7) and UBR5 (O95071), S. cerevisiae UBR1 (P19812) and A. thaliana UBR4 (At BIG;
At3g02260) and UBR5 (At PRT6; Q9LZ95) are each proposed to bind to a type 1 destabilizing residue. In contrast, Human UBR3 (Q6ZT12), UBR6 (Q86XK2) and UBR7 (Q8N806), A.
thaliana UBR7 (At4g23860) and S. cerevisiae UBR2 (Q07963) do not participate in the N-end rule pathway. Numbering is as described for human UBR1. Three zinc ions are
coordinated by two zinc ﬁnger motifs. One motif (highlighted in orange) coordinates a single zinc ion, the other unconventional motif (highlighted in yellow) coordinates two
adjacent zinc ions. Important N-degron contact residues are highlighted in different colors, the residues responsible for coordinating the N-terminal α-amino group (Phe148 and
Asp150) are in white text, the highly conserved acidic residues that interact with the basic side chain of the N-terminal residue (Asp118, Asp150 and Asp153) are highlighted in red,
the residues that contact the peptide bond (Thr120 and Phe148) are highlighted in blue. B. Molecular surface showing the electrostatic potential of the UBR box of S. cerevisiae UBR1
in complex with three different type 1 N-degron peptides [KIA (purple, PDB: 3NII), RIA (yellow, PDB: 3NIH) and HIA (cyan, PDB: 3NIJ)]. The surface is shaded in red (negatively
charged) and blue (positively charged). C-D. H-bond network (dotted lines) of selected residues that comprise the type 1 N-degron–binding pocket for (C) S. cerevisiae UBR1 (green)
in complex with RI (purple) (PDB: 3NIH) or (D) human UBR1 (dark blue) either in complex with RI-peptide (purple) (PDB: 3NY3) or free of peptide (cyan, PDB: 3NY1). Figures were
prepared using the program MacPyMOL (http://www.pymol.org).
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efﬁcient substrate unfolding by ClpAP requires an additional dynamic
interaction, between the displaced N-terminal loops on ClpP and the
pore-2 loops on the unfoldase [67,68]. This transient interaction is
sensitive to the nucleotide bound state of the unfoldase and is likely to
mediate the ﬁnal step of translocation into the peptidase chamber.
5.2. N-degron delivery to ClpAP
Although an N-terminal primary destabilizing residue is essential
for recognition by an N-recognin, this feature alone is not sufﬁcient for
its turnover. Substrates bearing anN-terminal destabilizing residue also
require a short unstructured region located near the N-terminus of the
target protein [8] and, in the case of eukaryotic substrates, an internal
Lys for attachment of a poly Ub chain. Importantly, both the length and
composition of this linker region can dramatically affect substrate
degradation. For bacterial N-end rule substrates, a stretch of at least
four amino acids (between the primary destabilizing residue and the
folded domain) is required for degradation to proceed [8,17,69]. In
general, negatively charged residues within the linker region are
disfavored, particularly those adjacent to the N-terminal destabilizing
residue, as they dramatically affect ClpS binding [8,69]. Consistent with
this notion, all known ClpS substrates lack negatively charged residues
adjacent to the N-terminal destabilizing residue [17,18]. The linker
region was also recently shown to contain a hydrophobic element (6–
12 residues downstream of the N-terminal destabilizing residue),
which is essential for delivery to ClpA, possibly through direct contactwith the pore-1 motif [17]. Indeed, a variant of PATase lacking this
hydrophobic element is a more potent inhibitor of ClpS-mediated
degradation (of a model N-end rule substrate) than wild type PATase,
suggesting that substrate transfer to ClpA is a highly coordinated
process. These ﬁndings are also consistent with the idea that substrate
delivery is an active processmediated by the hydrophobic element [45].
Currently our understanding of substrate unfolding and translo-
cation by the eukaryotic AAA+machinery is limited and hence the
following section will focus on the processing of a bacterial type 2
substrate by the AAA+protease, ClpAP. Nevertheless, given that these
machines share a number of common principles, some of the
mechanistic details described below are likely to apply to the 26S
proteasome. The current data suggest a model whereby the
degradation of a bacterial N-end rule substrate by ClpAPS is a highly
coordinated process. In the ﬁrst step, the target protein containing a
type 2 destabilizing residue at its N-terminus is bound by the
hydrophobic pocket on ClpS, which involves a network of speciﬁc
interactions with the α-amino group and the side chain of the N-
terminal residue and the ﬁrst peptide bond [22,23,46]. Upon
recognition of the substrate by ClpS, the ClpS-substrate complex is
delivered to ClpA in two steps; initially through docking to the N-
terminal domain of ClpA, which results in activation of ClpA by the N-
terminal tail of ClpS, to receive the N-end rule substrate [70–73]. This
“activation” step, is proposed to trigger a conformational change in
ClpA that permits engagement of the substrate, possibly between the
hydrophobic element on the substrate and the pore of ClpA [72–74].
Currently however, many of the details of N-degron delivery to ClpA
Fig. 4. The degradation of N-end rule substrates, by ATP-dependent machines is a highly coordinated process. A. In eukaryotes protein degradation is performed by the 26S
proteasome, which is composed of two compartments; a 20S core particle (CP) and a 19S regulator particle (RP). The CP is composed of 4 rings (two rings ofα-subunits and two rings
of β-subunits). The RP is composed of ~19 different subunits and can be divided into two functional regions, the lid (which is responsible for the deubiquitylation of the substrate)
and the base (which is required for activation of the CP and unfolding and translocation of the substrate). In the presence of ATP the C-terminal peptides (HbYX) from the unfoldase
subunits in the base activate the CP. Following delivery of the ubiquitylated substrate to the proteasome, the substrate is deubiquitylated by subunits in the lid, unfolded and
translocated (in an ATP-dependent fashion) into the CP, by a ring of ATPase subunits in the base. B. In bacteria, ClpP is formed from two heptameric rings stacked back-to-back. In the
absence of a cognate unfoldase, the pore of ClpP is blocked by its N-terminal peptides. The binding of ClpA (in the presence of ATP) opens the channel into the proteolytic chamber
thereby activating ClpP for general proteolysis. Subsequently, the substrate is delivered to the ClpAP complex via ClpS, the N-degron speciﬁc adaptor protein. In this case, substrate
delivery, by ClpS, is a critical step in N-degron degradation by ClpAP, as docking to the N-terminal domain of ClpA (and the subsequent binding reactions) is required to activate ClpA
for N-degron recognition, possibly through a hydrophobic element in the substrate and the pore of ClpA.
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does not involve the substrate binding pocket on the N-domain of
ClpA [75]. Consistently, although somewhat surprisingly, the ﬂexibil-
ity of the ClpA N-domain, which is proposed to regulate substrate
access to the pore of ClpA, does not appear to affect the processing of
N-end rule substrates delivered by ClpS [75,76]. In the next step,
following engagement of the substrate with the translocation pore,
ClpA uses the energy of ATP hydrolysis to drive conformational
changes within the translocation channel, which mediates unfolding
of the substrate [77]. In the case of ClpA (which contains two ATPase
domains) both domains work together to drive the unfolding and
translocation of substrates into ClpP [74].
Although numerous advances in the N-end rule pathway have
been made during the past 10 years, undoubtedly many more
discoveries lay just around the corner. Certainly, much remains to
be learnt about the newly discovered Ac-N-end rule pathway in yeast.
Also, little is known about the physiological role of the N-end rule
pathway in bacteria and currently even less is understood about the
N-end rule pathway in eukaryotic organelles. Therefore, many new
discoveries from each of these areas are eagerly anticipated.
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